IP Verse

Modified Rnai Agents - EP3366775

The patent EP3366775 was granted to Alnylam Pharmaceuticals on Aug 6, 2025. The application was originally filed on Nov 16, 2012 under application number EP17209680A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3366775

ALNYLAM PHARMACEUTICALS
Application Number
EP17209680A
Filing Date
Nov 16, 2012
Status
Patent Maintained As Amended
Jul 4, 2025
Grant Date
Aug 6, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

AWA SWEDENJan 27, 2023AWA SWEDENADMISSIBLE

Patent Citations (42) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS20040916185
DESCRIPTIONUS20040946873
DESCRIPTIONUS20050115989
DESCRIPTIONUS20070833934
DESCRIPTIONUS20070944227
DESCRIPTIONUS20080018611
DESCRIPTIONUS20080018616
DESCRIPTIONUS20080039748
DESCRIPTIONUS20080047087
DESCRIPTIONUS20080051228
DESCRIPTIONWO2007US80331
DESCRIPTIONUS4897355
DESCRIPTIONUS5171678
DESCRIPTIONUS5283185
DESCRIPTIONUS5328470
DESCRIPTIONUS7858769
DESCRIPTIONWO2007091269
DESCRIPTIONWO2007117686
DESCRIPTIONWO2009014887
DESCRIPTIONWO2010141511
DESCRIPTIONWO2011031520
DESCRIPTIONWO9116024
DESCRIPTIONWO9324640
DESCRIPTIONWO9400569
DESCRIPTIONWO9637194
DESCRIPTIONWO9839359
EXAMINATIONUS2006217331
EXAMINATIONWO2013163430
OPPOSITIONWO2007092059
OPPOSITIONWO2009134487
OPPOSITIONWO2011072082
OPPOSITIONWO2013074974
OPPOSITIONWO2013163430
OTHERUS2006217331
OTHERWO2009073809
SEARCHWO2007092059
SEARCHWO2009002944
SEARCHWO2009073809
SEARCHWO2009134487
SEARCHWO2010078536
SEARCHWO2011072082
SEARCHWO2011123468

Non-Patent Literature (NPL) Citations (50) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- AOKI et al., Cancer Gene Therapy, (20010000), vol. 8, pages 783 - 787
DESCRIPTION- BANGHAM et al., M. Mol. Biol., (19650000), vol. 23, page 238
DESCRIPTION- CHEN et al., Proc. Natl. Acad. Sci. USA, (19940000), vol. 91, pages 3054 - 3057
DESCRIPTION- CHOUNG et al., Biochemical and Biophysical Research Communications, (20060000), vol. 342, pages 919 - 927
DESCRIPTION- ELBASHIR et al., Genes Dev., (20010000), vol. 15, pages 188 - 200
DESCRIPTION- FEIGNER, J. Bioi. Chem., (19940000), vol. 269, page 2550
DESCRIPTION- FEIGNER, P. L. et al., Proc. Natl. Acad. Sci., USA, (19870000), vol. 8, pages 7413 - 7417
DESCRIPTION- FIRE et al., Nature, (19980000), vol. 391, pages 806 - 811
DESCRIPTION- FUKUNAGA et al., Endocrinol, (19840000), vol. 115, page 757
DESCRIPTION- GAO, X.; HUANG, L., Biochim. Biophys. Res. Commun., (19910000), vol. 179, page 280
DESCRIPTION- GERSHON, Biochem., (19930000), vol. 32, page 7143
DESCRIPTION- HAUBNER et al., Jour. Nucl. Med., (20010000), vol. 42, pages 326 - 336
DESCRIPTION- ITANI, T. et al., Gene, (19870000), vol. 56, pages 267 - 276
DESCRIPTION- KIM et al., Biochim. Biophys. Acta, (19830000), vol. 728, page 339
DESCRIPTION- LAM et al., Nature, (19910000), vol. 354, pages 82 - 84
DESCRIPTION- LEUSCHNER et al., EMBO Rep., (20060000), vol. 7, page 314
DESCRIPTION- MANNINO, R. J.; FOULD-FOGERITE, S., Biotechniques, (19880000), vol. 6, pages 682 - 690
DESCRIPTION- MAYER et al., Biochim. Biophys. Acta, (19860000), vol. 858, page 161
DESCRIPTION- MAYHEW et al., Biochim. Biophys. Acta, (19840000), vol. 775, page 169
DESCRIPTION- MORRISSEY et al., Hepatology, (20050000), vol. 41, page 1349
DESCRIPTION- MUHONEN et al., Chemistry & Biodiversity, (20070000), vol. 4, pages 858 - 873
DESCRIPTION- NABEL, Human Gene Ther, (19920000), vol. 3, page 649
DESCRIPTION- NABEL, Proc. Natl. Acad. Sci., (19930000), vol. 90, page 11307
DESCRIPTION- NICOLAU, C. et al., Meth. Enz., (19870000), vol. 149, pages 157 - 176
DESCRIPTION- OLSON et al., Biochim. Biophys. Acta, (19790000), vol. 557, page 9
DESCRIPTION- PLESSIS et al., Antiviral Research, (19920000), vol. 18, pages 259 - 265
DESCRIPTION- RAND et al., Cell, (20050000), vol. 123, page 621
DESCRIPTION- RIEGER, Pharmaceutical Dosage Forms, Marcel Dekker, Inc., (19880000), page 285
DESCRIPTION- ROSOFF, Pharmaceutical Dosage Forms, (19880000), vol. 1, page 245
DESCRIPTION- SCHWARZ et al., Curr. Biol., (20040000), vol. 14, page 787
DESCRIPTION- SIMEONI et al., Nucl. Acids Res., (20030000), vol. 31, pages 2717 - 2724
DESCRIPTION- STRAUBINGER, R. M.; PAPAHADJOPOULOS, D., Meth. Enz., (19830000), vol. 101, pages 512 - 527
DESCRIPTION- STRAUSS, EMBO J., (19920000), vol. 11, page 417
DESCRIPTION- SUBBARAO et al., Biochemistry, (19870000), vol. 26, pages 2964 - 2972
DESCRIPTION- SZOKA et al., Proc. Natl. Acad. Sci., (19780000), vol. 75, page 4194
DESCRIPTION- TURK et al., Biochem. Biophys. Acta, (20020000), vol. 1559, pages 56 - 68
DESCRIPTION- VOGEL et al., J. Am. Chem. Soc., (19960000), vol. 118, pages 1581 - 1586
DESCRIPTION- WANG, C. Y.; HUANG, L., Proc. Natl. Acad. Sci. USA, (19870000), vol. 84, pages 7851 - 7855
DESCRIPTION- WEINER et al., Journal of Drug Targeting, (19920000), vol. 2, pages 405 - 410
DESCRIPTION- ZHOU et al., Journal of Controlled Release, (19920000), vol. 19, pages 269 - 274
DESCRIPTION- ZHOU, X. et al., Biochim. Biophys. Acta, (19910000), vol. 1065, page 8
DESCRIPTION- ZITZMANN et al., Cancer Res., (20020000), vol. 62, pages 5139 - 43
EXAMINATION- DAVID V MORRISSEY ET AL, "Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs", NATURE BIOTECHNOLOGY, GALE GROUP INC, NEW YORK, vol. 23, no. 8, doi:10.1038/NBT1122, ISSN 1087-0156, (20050801), pages 1002 - 1007, (20050724), XP008157520
OPPOSITION- BRAASCH D.A. ET AL., "RNA interference in mammalian cells by chemically-modified RNA", Biochemistry, (20030101), vol. 42, no. 26, doi:10.1021/bi0343774, ISSN 0006-2960, pages 7967 - 7975, XP002328494
OTHER- DAVID V MORRISSEY et al., "Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs", NATURE BIOTECHNOLOGY, (20050724), vol. 23, no. 8, doi:10.1038/nbt1122, pages 1002 - 1007, XP008157520
SEARCH- THAZHA P PRAKASH ET AL, "Positional effect of chemical modifications on short interference RNA activity in mammalian cells", JOURNAL OF MEDICINAL CHEMI, AMERICAN CHEMICAL SOCIETY, vol. 48, no. 13, doi:10.1021/JM050044O, ISSN 0022-2623, (20050527), pages 4247 - 4253, (20070527), XP008155072 [Y] 1-13 * figures 3-5 *
SEARCH- MICHAEL A COLLINGWOOD ET AL, "Chemical Modification Patterns Compatible with High Potency Dicer-Substrate Small Interfering RNAs", OLIGONUCLEOTIDES, MARY ANN LIEBERT, NEW YORK, NY, US, (20080718), vol. 18, no. 2, doi:10.1089/OLI.2008.0123, ISSN 1545-4576, pages 187 - 200, XP002623649 [A] 1-13 * table 1 *
SEARCH- BEHLKE M A, "Chemical modification of siRNAs for in vivo use", OLIGONUCLEOTIDES, MARY ANN LIEBERT, NEW YORK, NY, US, vol. 18, no. 4, doi:10.1089/OLI.2008.0164, ISSN 1545-4576, (20081122), pages 305 - 320, (20081129), XP002546697 [A] 1-13 * table 1 *
SEARCH- CZAUDERNA F ET AL, "Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells", NUCLEIC ACIDS RESEARCH, INFORMATION RETRIEVAL LTD, GB, (20030601), vol. 31, no. 11, doi:10.1093/NAR/GKG393, ISSN 0305-1048, pages 2705 - 2716, XP002270732 [Y] 1-13 * figure 5 *
SEARCH- J. B. BRAMSEN ET AL, "A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity", NUCLEIC ACIDS RESEARCH, (20090312), vol. 37, no. 9, doi:10.1093/nar/gkp106, ISSN 0305-1048, pages 2867 - 2881, XP055000747 [A] 1-13 * tables 1,2 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents